BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock
PHGE.U
PHGE.U was delisted on the 24th of October, 2024.
0 hedge funds and large institutions have $0 invested in BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock in 2024 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $127 → $0 (-$127)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$126 |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| – | -$126 | -97 | Closed |
|
|
2
Bank of America
Charlotte,
North Carolina
| – | -$1 | -1 | Closed |
|
PHGE.U Hedge Fund Activity: Q4 2024 in Review
0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock (PHGE.U) for Q4 2024, worth a combined $0 — down 100% from $127 a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PHGE.U and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $126 sold.
- 0 institutional investors held BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock (PHGE.U) as of Q4 2024, down from 2 in Q3 2024.
- Funds reported $0 of BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock stock for Q4 2024, down 100% quarter-over-quarter.
- 0 funds opened new BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock positions in Q4 2024 and 2 closed out, a net change of -2 holders.
- The largest BiomX Inc. Units each consisting of one share of common stock and one Warrant entitling the holder to purchase one-half of a share of common stock seller in Q4 2024 was UBS Group, an estimated $126 sold.
Based on aggregated 13F filings for Q4 2024.